Mckesson stock price year-to-date

Year-to-date, "McKesson stock price" has outperformed the Dow Jones by 8 percentage points. Analysts attribute this to consistent dividend growth and strong industry fundamentals in U.S. pharma distribution. If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level and follow our free weekly MoneyFlows insights . For the current quarter, McKesson is expected to post earnings of $8.23 per share, indicating a change of +4.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +1.1% over the last 30 days. As of today, "McKesson stock price" is slightly up by 0.8%, outperforming the broader S&P 500 healthcare sector. Market sentiment is supported by higher prescription volumes and robust oncology drug distribution services. Analysts forecast moderate upside potential if inflation pressures ease.